Polaryx Therapeutics, Inc.
2 clinical trials · Sponsor
◉ Watch Polaryx Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol) (NCT07740512) | Polaryx Therapeutics, Inc. | 2026-12-01 |
| Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3 (NCT04637282) | Polaryx Therapeutics, Inc. | 2026-11-01 |
Track Polaryx Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.